Congenital thrombotic thrombocytopenic purpura (cTTP) related to ADAMTS-13 deficiency is associated with a maternal risk of death of 10% and a risk of fetal loss greater than 50% without treatment. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.